Waimei Tai, MD
Stroke and vascular neurologist
Medical Education: University of Maryland School of Medicine (2007) MD
Board Certification: Vascular Neurology, American Board of Psychiatry and Neurology
Board Certification, American Board of Psychiatry and Neurology, Vascular Neurology (2012)
Board Certification: Neurology, American Board of Psychiatry and Neurology (2011)
Fellowship, Clinical Excellence Research Center, Stanford University, healthcare systems design and delivery
Fellowship: Stanford University - Stroke (2012) CA
Residency: University of Southern California (2011) CA
Internship: Mercy Medical Center - University of Maryland (2008) MD
BA, The Johns Hopkins University, biology, economics (2003)
Honors & Awards
Boldrey Award in neuroscience research, San Francisco Neurological Society (May 2012)
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Secondary prevention of atherothrombotic or cryptogenic stroke.
Tai, W. A., & Albers, G. W. (2014). Secondary prevention of atherothrombotic or cryptogenic stroke. Circulation, 129(4), 527-531.
Multimodal Imaging Transcends Time in Thrombolysis For Pediatric Stroke
Waimei Amy Tai, Nerses Sanossian, Arthur Partikian, Monique Mogensen, Jesse Jones, & et al. (2012). Multimodal Imaging Transcends Time in Thrombolysis For Pediatric Stroke. Journal of Pediatric Neuroradiology.
Sex Specific Trends in Mortality Amongst Hospitalized Mid-Life Stroke Patients
Amytis Towfighi, Waimei Tai, Daniela Markovic, & Bruce Ovbiagele. (2011). Sex Specific Trends in Mortality Amongst Hospitalized Mid-Life Stroke Patients. Stroke, 42(10).